Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma.

Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma.
复制标题

DOI:
10.4161/onci.19964
复制
发表时间:
2012-07-01
期刊:
影响因子:
7.2
通讯作者:
Okada H
Okada H
中科院分区:
医学2区
文献类型:
--
作者:
Kohanbash G;Ishikawa E;Fujita M;Ikeura M;McKaveney K;Zhu J;Sakaki M;Sarkar SN;Okada H

文献摘要

参考文献

被引文献

相似文献

我们以前曾报道过IFNA 8的单核苷酸多态性(SNP)rs 12553612与AA基因型胶质瘤患者的总生存率比AC基因型患者更好相关。由于rs 12553612位于IFNA 8启动子中,我们假设A等位基因与C等位基因相比允许增强的IFNA 8启动子活性。在人单核细胞衍生的THP-1细胞系中的报告基因测定证明了与C-等位基因相比,A-等位基因的上级启动子活性。电泳迁移率变动分析(EMSA)进一步表明,A-基因型特异性结合更多的核蛋白比C-基因型,包括转录因子Oct-1。此外,编码Oct-1和报告构建体的质粒的共转染揭示了Oct-1增强了A-而不是C-等位基因的启动子活性。综上所述,我们的数据表明,rs 12553612 SNP中的A等位基因,这与更好的胶质瘤患者的生存率相关,允许IFNA 8通过允许Oct-1结合而转录,这在具有C等位基因的患者中是不存在的,并表明IFNA 8介导的胶质瘤进展的免疫监视的分子机制。
We have previously reported that the single nucleotide polymorphism (SNP) rs12553612 in IFNA8 is associated with better overall survival of glioma patients with the AA-genotype compared with patients with the AC-genotype. As rs12553612 is located in the IFNA8 promoter, we hypothesized that the A-allele allows for an enhanced IFNA8 promoter activity compared with the C-allele. Reporter assays in the human monocyte derived THP-1 cell line demonstrated a superior promoter activity of the A-allele compared with the C-allele. Electrophoretic mobility shift assays (EMSA) further demonstrated that the A-genotype specifically binds to more nuclear proteins than the C-genotype, including the transcription factor Oct-1. Further, co-transfection of plasmids encoding Oct-1 and the reporter constructs revealed that Oct-1 enhanced the promoter activity with the A- but not the C-allele. Taken together, our data demonstrate that the A-allele in the rs12553612 SNP, which is associated with better glioma patient survival, allows for IFNA8 transcription by allowing for Oct-1 binding, which is absent in patients with C allele, and suggests a molecular mechanism of IFNA8 mediated immune-surveillance of glioma progression.
DOI: 10.1084/jem.20101159
发表时间: 2011-09-26
期刊: The Journal of experimental medicine
影响因子: --
作者:
Fuertes MB;Kacha AK;Kline J;Woo SR;Kranz DM;Murphy KM;Gajewski TF
通讯作者: Gajewski TF
DOI: 10.1158/1055-9965.epi-07-0480
发表时间: 2007-11-01
影响因子: 3.8
作者:
Schwartzbaum, Judith A.;Ahlbom, Anders;Feychting, Maria
通讯作者: Feychting, Maria
DOI: 10.1016/j.vaccine.2008.01.017
发表时间: 2008-03-25
期刊: VACCINE
影响因子: 5.5
作者:
Dhiman, Neelam;Ovsyannikova, Inna G.;Poland, Gregory A.
通讯作者: Poland, Gregory A.
DOI: 10.1093/nar/26.1.362
发表时间: 1998-01-01
影响因子: 14.9
作者:
Heinemeyer, T;Wingender, E;Kolchanov, NA
通讯作者: Kolchanov, NA
DOI: 10.1084/jem.20101158
发表时间: 2011-09-26
期刊: The Journal of experimental medicine
影响因子: --
作者:
Diamond MS;Kinder M;Matsushita H;Mashayekhi M;Dunn GP;Archambault JM;Lee H;Arthur CD;White JM;Kalinke U;Murphy KM;Schreiber RD
通讯作者: Schreiber RD